Promacta 75 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FA3PS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,059
Award facts
- Contract value 100% obligated
- $24,059.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This contract, valued at $24,059.26 with firm fixed pricing, represents a non-set-aside award and is scheduled for completion by October 2, 2025. The pharmaceutical product will be delivered to the contractor's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal procurement presence as a critical vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a diverse range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The DLA utilizes the SPE2DX contract vehicle to enable flexible, efficient medical supply support for defense health customers, including the Defense Health Agency and U.S. Coast Guard, with the company competing successfully in an open procurement environment.
Quick answers
Who was awarded contract SPE2DB25FA3PS?
SPE2DB25FA3PS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FA3PS worth?
The government has obligated $24,059 on SPE2DB25FA3PS.
Is contract SPE2DB25FA3PS an order under another contract?
Yes. SPE2DB25FA3PS is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA3PS competed?
The extent of competition for SPE2DB25FA3PS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award